BamSEC and AlphaSense Join Forces
Learn More

Capricor Therapeutics Inc. – Material Contracts

NASDAQ: CAPR    
Share price (3/18/26): $30.90    
Market cap (3/18/26): $1.777 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 6 pages ​ Consulting Agreement
12/34/56
EX-10.1
from 10-Q 3 pages ​ Capricor Therapeutics, Inc. 2021 Equity Incentive Plan ​ Restricted Stock Award Agreement
12/34/56
EX-10.54
from 10-K 6 pages Fourth Amendment to Lease
12/34/56
EX-10.53
from 10-K ~5 pages ​ Amendment to Lease
12/34/56
EX-10.52
from 10-K ~5 pages Second Amendment to Lease
12/34/56
EX-10.51
from 10-K ~5 pages Amendment to Lease
12/34/56
EX-10.43
from 10-K 2 pages ​ First Amendment to Restated and Amended Employment Agreement
12/34/56
EX-10.41
from 10-K 2 pages ​ First Amendment to Restated and Amended Employment Agreement
12/34/56
EX-10.39
from 10-K 2 pages ​ First Amendment to Restated and Amended Employment Agreement
12/34/56
EX-10.36
from 10-K ~5 pages Sixth Amendment to Facilities Lease
12/34/56
EX-10.6
from 10-Q ~5 pages ​ Seventh Amendment to Facilities Lease ​
12/34/56
EX-10.1
from 10-Q 3 pages ​ *Portions of the Exhibit Have Been Excluded Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. ​ Term Sheet for Distribution of Deramiocel (Cap-1002) in Europe ​
12/34/56
EX-10.3
from 8-K 2 pages Letter of Intent September 16, 2024 ​ Confidential ​ Capricor Therapeutics, Inc. ​ Dear Dr. Linda Marbán: ​
12/34/56
EX-10.2
from 8-K 19 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 23 pages Signature Page to Subscription Agreement
12/34/56
EX-10.1
from 8-K 21 pages Securities Purchase Agreement ​
12/34/56
EX-10.55
from 10-K 48 pages *Portions of the Exhibit Have Been Excluded Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Commercialization and Distribution Agreement
12/34/56
EX-10.55
from 10-K 42 pages *Portions of the Exhibit Have Been Excluded Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Commercialization and Distribution Agreement
12/34/56
EX-10.54
from 10-K 47 pages *Portions of the Exhibit Have Been Excluded Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Standard Industrial/Commercial Multi-Tenant Lease Net
12/34/56
EX-10.3
from 10-Q 9 pages ​ Capricor Therapeutics, Inc. ​ 2021 Equity Incentive Plan ​ Stock Option Agreement
12/34/56